Nongenomic effects of oestrogen: embryonic mouse midbrain neurones respond with a rapid release of calcium from intracellular stores
- 1 January 1998
- journal article
- research article
- Published by Wiley in European Journal of Neuroscience
- Vol. 10 (1) , 255-262
- https://doi.org/10.1046/j.1460-9568.1998.00045.x
Abstract
Evidence is emerging that oestrogen, besides acting via classical nuclear receptors, can rapidly influence the physiology of nerve cells through other mechanisms. Oestrogens have been shown to modulate the differentiation and function of embryonic midbrain dopaminergic neurones by stimulating neurite outgrowth, expression of tyrosine hydroxylase mRNA, dopamine uptake and release in spite of the fact that dopaminergic cells in the prenatal midbrain do not express the classical oestrogen receptor. This study therefore intended to unravel possible signal transduction pathways activated by oestrogen which might be associated with the above oestrogen effects. As a physiological second‐messenger mechanism, we studied the influence of oestrogen on fluctuations of intracellular Ca2+ levels [Ca2+]i by microspectrofluorimetry of the Ca2+‐sensitive indicator Fura‐2, in primary cultures from embryonic mouse midbrains. 17β‐estradiol (10 n m–1 p m) but not 17α‐estradiol increased [Ca2+]i within 1–3 s in a dose‐dependent way. Removal of extracellular Ca2+ abrogated K+‐stimulated Ca2+ rise but did not affect 17β‐estradiol stimulation. Pretreatment of cells with thapsigargin (1 μm, 10 min), an inhibitor of Ca2+‐pumping ATPases in the endoplasmic reticulum, abolished the 17β‐estradiol effect but not the K+‐stimulated [Ca2+]i rise. Oestrogen effects on [Ca2+]i were completely mimicked by using a membrane‐impermeant oestrogen‐BSA construct. In order to identify oestrogen‐sensitive cells, some cultures were subsequently immunostained for microtubule‐associated protein II, tyrosine hydroxylase, or GABA. All oestrogen‐sensitive cells were immunocytochemically characterized as neurones, and about half of these responsive neurones was found to be dopaminergic or GABAergic. These results demonstrate that 17β‐estradiol is capable of rapidly modulating physiological parameters of developing midbrain neurones by directly interacting with specific membrane binding sites coupled to a signal transduction mechanism that causes a calcium release from intracellular Ca2+ stores. It is suggested that oestrogen effects on differentiation and function of midbrain dopaminergic neurones are mediated by intracellular Ca2+ signalling.Keywords
This publication has 66 references indexed in Scilit:
- Androgens stimulate the morphological maturation of embryonic hypothalamic aromatase-immunoreactive neurons in the mouseDevelopmental Brain Research, 1997
- Genotype-dependent sex differentiation of dopaminergic neurons in primary cultures of embryonic mouse brainDevelopmental Brain Research, 1996
- Membrane receptors for estrogen, progesterone, and testosterone in the rat brain: Fantasy or realityCellular and Molecular Neurobiology, 1996
- 17β-estradiol in vitro affects Na-dependent and depolarization-induced Ca2+ transport in rat brain synaptosomesCellular and Molecular Life Sciences, 1996
- Derivatives of thapsigargin as probes of its binding site on endoplasmic reticulum Ca2+ ATPaseFEBS Letters, 1993
- Actions of 17β-Estradiol on Gonadotropin Release Induced by Drugs That Activate Intracellular Signal Transduction Mechanisms in Rat Anterior Pituitary Cells1Biology of Reproduction, 1988
- Rapid effects of gonadal steroids upon hypothalamic neuronal membrane ultrastructureJournal of Steroid Biochemistry, 1987
- Estradiol membrane binding sites on human breast cancer cell lines. Use of a fluorescent estradiol conjugate to demonstrate plasma membrane binding systemsThe Journal of Steroid Biochemistry and Molecular Biology, 1986
- Steroid binding to synaptic plasma membrane: Differential binding of glucocorticoids and gonadal steroidsThe Journal of Steroid Biochemistry and Molecular Biology, 1983
- Affinity cytochemistry visualizes specific estrogen binding sites on the plasma membrane of breast cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1981